期刊文献+

抗心磷脂抗体阳性复发性流产患者肝素治疗的抗凝监测 被引量:4

下载PDF
导出
摘要 目的:观察抗凝疗法治疗抗心磷脂抗体(ACA)阳性复发性流产患者的安全性和有效性。方法:2005年2月至2006年11月,广东省计划生育专科医院收治了113例ACA阳性复发性流产患者,其中58例采用阿司匹林和肝素联合治疗(阿司匹林+肝素组),另55例仅用阿司匹林治疗(阿司匹林组),观察和比较两组的妊娠情况,并检测孕前、早孕、中孕、晚孕时的血小板数(PLT)和活化部分凝血活酶时间(APTT)。结果:阿司匹林组治疗后未再发生流产者36例,总妊娠成功率为65/(36/55);阿司匹林+肝素组治疗后未再发生流产者46例,妊娠成功率79/(46/58),联合治疗的妊娠成功率稍有提高,但其差异无显著性。治疗后孕前和早孕阶段,APTT和PLT在两组间差异无显著性,但在中孕和晚孕阶段,阿司匹林+肝素组的APTT和PLT则显著高于阿司匹林组。结论:小剂量、短疗程阿司匹林和肝素联合治疗方案治疗ACA阳性复发性流产患者的妊娠成功率略有提高,并且是有效的、安全的。
出处 《实用医学杂志》 CAS 2007年第11期1668-1669,共2页 The Journal of Practical Medicine
基金 广东省人口和计划生育委员会科研课题资助项目(编号:2004003)
  • 相关文献

参考文献5

二级参考文献103

  • 1林其德,肖云山.抗磷脂综合征与病理妊娠[J].中国实用妇科与产科杂志,2004,20(5):264-266. 被引量:42
  • 2林其德,周涵春.原因不明性习惯性流产的免疫学诊断与治疗[J].中华妇产科杂志,1993,28(3):143-146. 被引量:41
  • 3林其德,周涵春.复发性流产与自身抗体关系的探讨[J].中华妇产科杂志,1993,28(11):674-677. 被引量:49
  • 4Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol, 2003,101 (6): 1333-1344
  • 5Vinatier D, Dufour P, Cosson M, et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol,2001,96(1) :37-50
  • 6Chamley LW. Antiphospholipid antibodies: biological basis and prospects for treatment. J Reprod Immunol, 2002,57(1 ): 185-202
  • 7Voss A, Jacobsen S, Heegaard NH. Association of beta2-glycoprotein IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus, 2001,10(8): 533-538
  • 8Lockshin MD,Branch DW,Piette JC,et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999,42(50): 1309-1331
  • 9Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun, 2000,15 ( 1 ): 163-172
  • 10Vinatier D,Dufour P,Cosson M,et al.Antiphospholipid syndrome and recurrent miscarriages[J].Eur J Obstet Gynecol Reprod Biol,2001,96(1):37-50.

共引文献94

同被引文献31

  • 1陶娅玲,漆洪波.子痫前期/子痫病因学研究进展[J].中华妇幼临床医学杂志(电子版),2007,3(3):174-176. 被引量:27
  • 2Kupfermine MJ. Thrombophilia and preeclampsia: the evidence so far[J]. Clin Obstet Gyneeol , 2005,48:406-415.
  • 3Brenner B, Bar J, Ellis M, et al. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study[ J]. Fertil Steril,2005, 84:770-773.
  • 4Kalk JJ,Huisjes AJ, de Groot CJ. et al. Recurrence rate ofpreeclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment? [ J]. Neth J Med, 2004, 62 ( 3 ) :83-87.
  • 5Nakabayashi M, Asami M, Nakatani A. Efficacy of antithrombin replacement therapy in severe early-onset preeclampsia [J]. Semin Thromb Hemost, 1999,25 ( 5 ) :463-466.
  • 6Hiroshi S, Yuki K, Tsuyomu I, et al. Antithrombin improves fetal condition in women with severe pre-eclampsia before 32 weeks of gestation : a randomized, double-blind, placebo-controlled trial[J]. J Obstet Gynaecol Res,2008 ,34 :34-39.
  • 7Zeev B, Benjamin B. Thrombophilia-associated pregnancy wastage [ J ]. Fertil Steril, 1999,5 ( 72 ) : 765-774.
  • 8Saisto T,Tiitinen A, Ulander VM, et al. Clinical cure of severe, early onset pre-eclampsia with low molecular weight heparin therapy in primigravida with hyperreaction luteinalis and thrombophilia [J]. Human Reprod,2004, 19(3) :725-728.
  • 9Kupferminc MJ, Fait G, Many A, et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilia [ J ]. Hypertens Pregnancy, 2001,20 ( 1 ) : 35- 44.
  • 10Mello G, Parretti E, Fatini C, et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women [ J]. Hypertension, 2005, 45( 1 ):86-91.

引证文献4

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部